New
New Drug May Reduce Need For Aortic Valve Surgeries By Slowing Disease Progression
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage AVS. Results from preclinical and clinical studies show that ataciguat has the potential to significantly slow disease progression.
Popular Products
-
Height Adjustable Electric Chair Lift...$661.99$395.78 -
Portable Under Desk Elliptical for Se...$290.99$202.78 -
Invisible Rechargeable Hearing Aids w...$160.99$111.78 -
Secure Shoe Inserts$30.99$20.78 -
Stair Chair Evacuation Wheelchair$509.99$355.78